Physician Wealth Advisors’s Vaxcyte PCVX Stock Holding History

Physician Wealth Advisors’s Portfolio PCVX Stock Details PCVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.45K	Sell	25 -69	-73%	-$3.75K	﹤0.01%	1654
2026 Q1	$5.46K	Sell	94 -2	-2%	-$109	﹤0.01%	981
2025 Q4	$4.43K	Buy	96 +9	+10%	+$403	﹤0.01%	1006
2025 Q3	$3.13K	Buy	87 +26	+43%	+$861	﹤0.01%	1055
2025 Q2	$1.98K	Buy	61 +47	+336%	+$1.54K	﹤0.01%	1046
2025 Q1	$529	Buy	+14	New	+$1.12K	﹤0.01%	1360

Other funds holding PCVX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Jupiter Topco New York $245B AUM

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Physician Wealth Advisors's PCVX Position: Q2 2026 in Review

Physician Wealth Advisors reduced its Vaxcyte (PCVX) stake by 73% in Q2 2026, selling an estimated $3.75K and leaving 25 shares worth $1.45K. The position accounts for ﹤0.01% of the portfolio, ranked #1654.

Physician Wealth Advisors first reported a position in PCVX in Q1 2025 and has held it in 6 quarters since. The position peaked at $5.46K in Q1 2026. 332 funds tracked by Wall St. Rank hold PCVX as of Q2 2026.

Physician Wealth Advisors held 25 shares of Vaxcyte worth $1.45K as of Q2 2026.
Physician Wealth Advisors sold 69 Vaxcyte shares in Q2 2026, an estimated $3.75K.
Vaxcyte made up ﹤0.01% of Physician Wealth Advisors's portfolio in Q2 2026, its #1654 holding.
Physician Wealth Advisors first reported a position in Vaxcyte in Q1 2025 and has held it in 6 quarters since.
Physician Wealth Advisors's Vaxcyte position peaked at $5.46K in Q1 2026.
332 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2026.

Based on Physician Wealth Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.